Interferon-α (IFN-α) induces the transfer of resistance to hepatitis B virus (HBV) from 24 liver nonparenchymal cells (LNPCs) to hepatocytes via exosomes. However, little is 25 known about the entry machinery and pathway involved in the transmission of 26 IFN-α-induced antiviral activity. Here, we found that macrophage exosomes depend on T 27 cell immunoglobulin and mucin receptor 1 (TIM-1), a hepatitis A virus (HAV) receptor, to 28 enter hepatocytes for delivering IFN-α-induced anti-HBV activity. Moreover, two primary 29 endocytic routes for virus infection, clathrin-mediated endocytosis (CME) and 30 macropinocytosis, collaborate to permit exosome entry and anti-HBV activity transfer. 31
Introduction 51
Hepatitis B virus (HBV) is a small, enveloped DNA virus that replicates via an RNA 52 intermediate and belongs to the Hepadnaviridae family(1). Approximately 400 million 53 people are chronically infected with HBV worldwide(2). Chronic HBV infection is a major 54 risk factor for the development of liver cirrhosis and hepatocellular carcinoma(3). 55
Interferon (IFN)-α is licensed for the treatment of HBV chronic infection, with a response 56 rate of 30-40% and a clinical cure rate of approximately 10%(4), but its efficacy is limited 57 in hepatocytes (5, 6) . We and others previously reported that IFN-α induced the transfer 58 of resistance to hepatitis viruses from nonpermissive liver nonparenchymal cells 59 (LNPCs), including liver resident macrophages, to permissive hepatocytes via exosomes, 60 but the underlying mechanism remains largely unclear(7-11). 61
Exosomes are 40-100 nm membrane vesicles derived from the intraluminal 62 vesicles (ILVs) of multivesicular bodies (MVBs) that are secreted into the extracellular 63 milieu through the fusion of MVBs with the plasma membrane(12, 13). These vesicles 64 can serve as mediators of intercellular communication to exchange functional proteins, 6 / 37 (640905) was purchased from Biolegend (San Diego, USA). Phalloidin-iFluor 488 (23115) 94 was from AAT Bioquest (Sunnyvale, USA). Fc-TIM-1-His, a protein of TIM-1 extracellular 95 domain (AAC39862.1) (Ser 21-Gly 290) which is fused with a polyhistidine tag at the 96 C-terminus and the Fc region of human IgG1 at the N-terminus was from Sino Biological 97 (Beijing, China). Aldehyde/Sulfate Latex Beads(4% w/v, 4 µm) was from Invitrogen 98 (Carlsbad, USA). 99
Chemical inhibitors including dynasore (D7693), MβCD (C4555), EIPA (A3085), 100 IPA-3 (I2285) and rottlerin (R5648) were from Sigma-Aldrich. Filipin III (70440) was 101 purchased from Cayman chemical (Ann Arbor, USA). Chlorpromazine (S2456) and 102 nystatin (S1934) were purchased from Selleck Chemicals (Houston, USA). 103
Cells, plasmids, siRNAs and transfection 104
The HepG2.2.15, HepG2 and THP-1 cells used in this study have been described 105 previously(7, 24). HepG2.2.15 and HepG2 cells were cultured in DMEM with 10% fetal 106 bovine serum (FBS) (Biologic Industries, Beit
Haemek, Israel) and 107
Penicillin-Streptomycin (Invitrogen, Carlsbad, USA), while THP-1 cells were maintained 108 in RPMI-1640 with 10% FBS and antibiotics. To obtain macrophage-like cells that closely 109 resembled human monocyte-derived macrophages, THP-1 cells were differentiated via 110 7 / 37 a gift from Sandra Schmid (Addgene plasmid # 34687). pcDNA3-EGFP-Cdc42-T17N 116 (Addgene plasmid # 12976) and pcDNA3-EGFP-Rac1-T17N (Addgene plasmid # 12982) 117
were gifts from Gary Bokoch. Caveolin-1 labeled with C-terminal tag of enhanced green 118 fluorescent protein (EGFP) was constructed by insertion of the claveolin-1 cDNA 119 fragment into a pEGFP-N1 expression vector (Clontech, Palo Alto, USA). To produce 120 GFP-carrying exosomes, a THP-1 cell line stably expressing GFP was established via 121 lentivirus transduction. The lentiviral vector PLJM1-GFP (Addgene) was used to 122 generate lentivirus for the transduction, according to the manufacturer's instructions 123 (Addgene). Stable GFP-expressing THP-1 cells were selected by flow cytometric sorting 124 (BD FACSAria II; BD Biosciences, San Jose, USA). siRNAs for clathrin heavy chain, 125
caveolin-1 and negative control were purchased from Santa Cruz Biotechnology. siRNA 126 for TIM-1 was purchased from Ruibo. 127 DNA plasmid transfection into HepG2 cells was performed using Lipofectamine 128 2000 (Invitrogen). For RNA-mediated interference, HepG2 cells at 30 to 40% confluence 129 were transfected with 50 nM small interfering RNA (siRNA) duplexes designed and 130 8 / 37 exosomes by overnight centrifugation at 100,000 g). Exosomes from the culture 138 supernatants were isolated by differential centrifugation, as described previously (7) . To 139 obtain exosomes from IFN-α-treated macrophages, the macrophages were treated for 140 48 h with 1,000 U/ml of IFN-α (PBL Assay Science, New Brunswick, USA) before 141 isolation. The purified exosomes were characterized via electron microscopy and 142 immunoblot analysis, as described previously (7) . Protein amounts of exosomes were 143 quantified using a BCA protein assay kit (Pierce, Rockford, USA). 144
The isolated exosomes were labeled with PKH67 or PKH26 according to the 145 manufacturer's protocol (Sigma-Aldrich) for use in endocytosis assays. For the 146 fluorescence self-quenching assay for membrane fusion, R18 (Octadecyl Rhodamine B 147 Chloride, Invitrogen) was inserted into the viral membranes at a self-quenching surface 148 density (27, 28) . 149
Endocytosis assays of exosomes 150
To assay exosome internalization, 10-20 µg/ml of labeled exosomes were added to 151
HepG2 cells cultured with serum-free medium and incubated at 37℃. HepG2 cells were 152 untreated or pretreated with the indicated amounts of inhibitors for 30 min before 153 incubation with exosomes or endocytic markers. Except cholesterol inhibitors (MβCD, 154 nystatin, and filipin III), inhibitory compounds were present continuously during 155 subsequent endocytosis assays. Despite moderate cytotoxicity of MβCD-treated cells, 156 no significant toxicity was observed for the other inhibitors (data not shown), which 157 indicated that inhibition of exosome internalization was not caused by cytotoxicity. As 158 controls, HepG2 cells were incubated with 2 µg/ml of Alexa568-transferrin (Invitrogen) or 9 / 37 0.2 mg/ml of dextran labeled with Rhodamine B isothiocyanate (RhoB-dextran, 160
Sigma-Aldrich) for 30 min or 1 h at 37℃. For competitive inhibition of TIM-1-mediated 161 exosome entry by Fc-TIM-1-His, HepG2 cells were incubated with labeled exosomes in 162 presence of 1 µg/ml Fc-TIM-1-His at 37℃ for 2 h. Endocytosis was stopped, and 163 surface-bound exosomes or markers were removed by washing with ice-cold PBS. 164
Confocal laser-scanning and time-lapse microscopy 165
Confocal images were captured using a Leica TCS SP8 confocal microscope (Leica 166
Microsystems, Buffalo Grove, USA) with a 400X or 630X oil objective (pinhole set at 1 167
Airy unit) and processed using LAS X (Leica). For time-lapse microscopy analysis, 168
HepG2 cells were grown in 35-mm glass bottom culture dishes with four chambers 169 (Cellvis, Mountain View, USA) overnight. Before microscopic examination, the medium 170 was changed to serum-free DMEM, and fluorescence-labeled exosomes were added 171 and kept in the medium during image collection. Time-lapse images were captured every 172 10 min for 6-µm slices using a DeltaVision Elite high-resolution microscope (Applied 173 Precision, Issaquah, USA) connected to a 37°C incubator and buffered with 5% CO 2 . 174
The images were further processed with softWoRx Explorer (Applied Precision, 175
Issaquah, USA) and analyzed with ImageJ (NIH, USA). For colocalization studies, the 176 distribution patterns of the fluorescent signals were analyzed using the Plot Profile 177 analysis tool of ImageJ, and Pearson's correlation coefficients (Rr) were obtained by 178 using the Colocalization finder plugin of ImageJ. For the Pearson's correlation 179 coefficients (Rr), the values ranged from 1 (a perfect positive correlation) to −1 (a perfect 180 negative correlation), with 0 representing a random distribution(29). Time-related 10 / 37 fluorescence intensities of the R18 dequenching signals were assessed using the Time 182
Series Analyzer V3 plugin of ImageJ. 183
Flow cytometry analysis 184
For endocytosis assay, cells were washed three times with ice-cold PBS, detached 185 using trypsin, and subsequently resuspended in PBS with 1% FBS. Flow cytometry 186 analysis was performed on an LSR Fortessa instrument integrated with the FACSDiva 187 software (BD Biosciences). A minimum of 10,000 events within the gated live cells were 188 collected and analyzed per sample using FlowJo (Tree Star, Ashland, USA). macrophage-derived exosomes through annexin-V labeling of exosomes isolated from 231 macrophages ( Fig. 1 E) . 232
We then inhibited the expression of two hepatic PtdSer receptors involved in virus 233 entry(31), T cell immunoglobulin and mucin receptor 1 (TIM-1) ( Fig. 1F ) and Growth 234 Arrest Specific 6 (GAS6) (data not shown), in HepG2 cells with specific siRNAs. The 235 uptake of PKH26-labeled exosomes was significantly reduced in HepG2 cells after TIM-1 236 knockdown ( Fig. 1G and H), but interference via GAS6 expression had no effect on 237 exosome uptake (data not shown). It is notable that the IgV in ectodomains of TIM 238 proteins bind PtdSer on viral envelope and enhance virus entry(32). Exogenous 239
Fc-TIM-1-His, TIM-1 extracellular domain fused with His tag and Fc region of human 240 IgG1, competitively inhibited exosome internalization by HepG2 cells ( Figure 1I ), which 241 suggested that the ectodomain of TIM-1 also play a functional role in exosome entry. 242
Corresponding to previous results reflecting the engagement of TIM-1 in exosome 243 uptake, IFN-α-induced anti-HBV activity mediated by exosomes from IFN-α-stimulated 244 macrophages (IFN-EXO) was diminished in TIM-1-knockdown HepG2.215 cells in 245 comparison to that in cells transfected with control (ctrl) siRNA, as indicated by HBsAg 246 expression ( Fig. 1J ). In addition, IFN-α-induced exosome-mediated antiviral activity only 247 slightly suppressed HBV DNA production in the supernatant of TIM-1-knockdown cells, 248 in contrast to cells transfected with ctrl siRNA (Fig. 1K ). It was unexpected that the 249 knockdown of TIM-1 caused a decrease in HBV DNA in the supernatant, which suggests 250 that TIM-1 is a positive factor for HBV replication (Fig. 1K ). Collectively, these findings 251 demonstrated that PtdSer and its receptor TIM-1 act as portals for exosomal 252 internalization and the transfer of IFN-α-induced antiviral activity against HBV. 253 254 Dynamin-2 and cholesterol are required for exosome entry into hepatocytes 255
The interaction of exosomes with receptors on donor cells can induce the cellular 256 response of internalization through endocytic pathways(33). Endocytosis occurs via 257 several pinocytic mechanisms that include the clathrin-mediated mechanism, 258 macropinocytosis, the caveolae-mediated mechanism and other less well-defined 259 mechanisms(34, 35). The large GTPase dynamin-2 functions at the heart of endocytic 260 vesicle fission in clathrin-mediated endocytosis (CME) and caveolae-mediated 261 endocytosis ( Fig. 2A )(36). Recent studies showed that dynamin is also responsible for 262 the closure of circular ruffles in macropinocytosis ( Fig. 2A )(37). Cholesterol plays 263 essential roles in the formation of caveolae, clathrin-coated pit budding and membrane 264 ruffling in macropinocytosis ( Fig. 2A ) (38) (39) (40) . 265
To investigate the role of dynamin-2 in exosome entry, we suppressed the function 266 of dynamin-2 in HepG2 cells with the specific inhibitor dynasore. The efficacy of 267 dynasore was confirmed using Alexa568-labeled transferrin (Alexa568-TFN), which is 268 the best-characterized cargo protein of CME ( Fig. 2B and C). The uptake of 269 PKH26-labeled exosomes was reduced by approximately 60% following dynasore 270 treatment ( Fig. 2C ). In addition, the expression of the dominant-negative mutant of 271 dynamin-2, Dyn2K44A, also significantly blocked exosome entry ( Fig. 2D ). We next 272 sought to determine whether cholesterol is necessary for exosome entry into 273 hepatocytes. Using Methyl-β-cyclodextran (MβCD) to extract cholesterol from the 15 / 37 plasma membrane of HepG2 cells significantly inhibited PKH26-labeled exosome entry 275 ( Fig. 2E and F). The reduction was up to 86% when treating HepG2 cells with 10 mM 276 MβCD (Fig. 2 F) . Masking cholesterol with binding compounds (nystatin and filipin) 277 resulted in milder but still apparent inhibition of exosome uptake by HepG2 cells (Fig. 2E , 278 G and H). These results indicated that the dynamin-2-and cholesterol-dependent 279 endocytic pathways are required for the entry of exosomes into hepatocytes. 280 281
Clathrin-but not caveolae-mediated endocytosis is important for exosome uptake 282 and the transmission of IFN-α-induced anti-HBV activity 283
CME, which is the uptake of material into cells from the surface using 284 clathrin-coated vesicles, is the preferred route by which some PtdSer-exposing viruses 285 enter target cells(31). To investigate the dependence of exosome entry on CME, 286 hepatocytes were treated with chlorpromazine (CPZ), an inhibitor of clathrin-coated pit 287
assembly. PKH26-labeled exosome uptake decreased by 34%, and as a positive control, 288 transferrin uptake was inhibited under the same conditions ( Fig. 3A and B ). Moreover, 289 knockdown of the clathrin heavy chain (CHC) also reduced exosome entry into 290 hepatocytes by 34% ( Fig. 3C and D). To further investigate the endocytic pattern 291 engaged in exosome entry, exosomes were stained with PKH67 and administered to 292 correlation coefficient (Rr) and an intensity profile were used to quantify the degree of 297 colocalization between PKH67-labeled exosomes and Alexa568-TFN. Partial 298 colocalization between exosomes and transferrin was evidenced by scatterplots, a 299 fraction of which were close to diagonal, and the corresponding Rr was 0.1292 (see 300
Materials and Methods) ( Fig. 3E ). There were several peak superpositions in the 301 intensity profile (Fig. 3E ). Correspondingly, the downregulation of CHC expression in 302 HBV-replicating hepatocytes weakened the IFN-α-induced anti-HBV activity transmitted 303 by exosomes in HepG2.2.15 cells, as indicated by viral antigen expression and DNA 304 quantification ( Fig. 3G and H ). In addition, caveolae-mediated endocytosis did not 305 appear to be required for exosome internalization by hepatocytes, as indicated by the 306 inhibition of caveolin-1 (CAV1) expression ( Fig. 3I and J). Together, these data showed 307 that clathrin-but not caveolae-mediated endocytosis contributed to exosome uptake and 308 the transfer of IFN-α-induced HBV resistance. 309 310 Macropinocytosis plays an alternative role in exosome uptake and the transfer of 311
IFN-α-induced anti-HBV activity 312
More than one endocytic route was reported to be used in virus or exosome 313 entry(33, 41). Given the incomplete inhibition of exosome entry by blockade of CME and 314 the sustained increase of internalized exosomes for hours ( Fig. 1D and 3B, D), there 315 might be alternative pathways to support exosome entry into hepatocytes. 316
Macropinocytosis is a fluid-phase type of endocytosis that is accompanied by membrane 317 ruffles regulated by actin rearrangement(37). This process is engaged in apoptotic cell 318 removal and is favored by some viruses that use apoptotic mimicry to enter target 319 cells(31). 320
The induction of a robust increase in fluid-phase uptake is a hallmark of 321 macropinocytosis(39). The results showed that the uptake of 70-kDa dextran labeled 322
with Rhodamine B isothiocyanate (RhoB-dextran), which is a fluid-phase marker specific 323 for macropinocytosis, was enhanced by incubation with macrophage-derived exosomes 324 in HepG2 cells ( Fig. 4A) . A Na+/H+ exchanger (NHE) is needed for macropinosome 325 formation via the modulation of Rho GTPases at the plasma membrane, and NHE 326 inhibition by 5-(N-Ethyl-N-isopropyl) amiloride (EIPA) has been widely used as a 327 diagnostic criterion for macropinocytosis(42). The entry of both exosomes and dextran 328 into HepG2 cells was apparently inhibited by EIPA, and a remarkable decrease (80%) in 329 exosome uptake was achieved in the presence of 80 nM EIPA ( Fig. 4B and C). PAK1 and 330 PKC are two serine/threonine kinases that are required for macropinocytosis(39). We 331 found that exosome entry was markedly blocked by the PAK1 inhibitor IPA-3 and the 332 PKC inhibitor rottlerin ( Fig. 4D-F ). PKC inhibition resulted in a more significant reduction 333 in exosome internalization by up to 66% in hepatocytes ( Fig. 4F ). As a positive control, 334 dextran internalization was greatly inhibited by the two kinase inhibitors ( Fig. 4 D-F) . 335
However, the expression of a dominant-negative mutant of Rac1 or Cdc42, two common 336
GTPases that modulate membrane ruffles, had no effect on exosome internalization ( Fig.  337 4G and H), which suggested that macrophage exosomes might enter hepatocytes via a 338
Rac1-or Cdc42-independent route. Next, we reinvestigated the role of macropinocytosis 339 in exosome entry by comparing the distribution patterns of dextran and exosomes after 340 internalization. In contrast to that seen for rapid CME-dependent exosome uptake, 341 confocal images showed consistent colocalization of PKH67-labeled exosomes with 342
RhoB-dextran-filled intracellular vacuoles ( Fig. 4I and J) . A highly overlapped distribution 343 was observed 1 h post-exosome internalization and was confirmed by the corresponding 344 scatterplots, colocalization coefficient and intensity profile ( Fig. 4J ). Furthermore, the 345 inhibition of macropinocytosis in HepG2.2.15 cells by EIPA partially blocked the 346 IFN-α-induced anti-HBV activity mediated by exosomes derived from IFN-treated 347 macrophages, as indicated by viral DNA quantification ( Fig. 4K ). Thus, we concluded 348 that macropinocytosis served as a sustained alternative route that was active from the 349 early stage of exosome internalization and cooperated with CME to ensure hepatocytes 350 the access to exosome-mediated HBV resistance. We first used time-lapse microscopy to track membrane fusion events in live 363 hepatocytes incubated with macrophage-derived exosomes prelabeled with 364 self-quenching amounts of the hydrophobic dye rhodamine C18 (R18). R18 is commonly 365 used as a fluorescent probe to detect virus-induced membrane fusion. The probe is 366 incorporated into membranes at high concentrations to cause self-quenching, and 367 dequenching of the probe occurs when membrane fusion decreases in density (27, 28) . 368
The dequenching signal of membrane fusion was first captured approximately 45 369 minutes after treating HepG2 cells with R18-labeled exosomes, and fusion events 370 followed within 1 hour (Fig. 5B ). The fluorescence intensity profile showed persistent 371 enhanced R18 fluorescence for the fusion spots ( Fig. 5C) . To track exosomal cargo after membrane fusion, the live dynamics of exosomal 385 cargo in hepatocytes were tested by monitoring the membrane fusion events of 386 R18-labeled GFP-carrying exosomes using time-lapse microscopy, with exosomes 387 isolated from GFP-expressing macrophages. At the beginning of the experiment, orange 388 fluorescence was observed at the fusion site due to the combined fluorescence emitted 389 by dequenching R18 inserted into exosome membranes and GFP encapsulated in 390 exosomes. As fusion proceeded, the extreme dilution of the R18-labeled membrane 391 components increased the fluorescence of the gradually exposed GFP. A complete color 392 switch was accomplished when the exosomal cargo GFP was totally uncoated and 393 "released" (Fig. 5E ). In addition, confocal images proved again that LEs were the site of 394 membrane fusion for GFP-carrying exosomes (Fig. 5F ). The colocalization coefficient of 395 Notably, the LE-specific anionic lipid LBPA assists as both viruses and delivery vectors to 405 achieve efficient cytosolic access via membrane fusion-induced endosome 406 penetration(43-48). 407
The accumulation of PKH26-labeled exosomes in the LBPA-rich structure 408 suggested a potential interaction between the two components ( Fig. 6A ). Partial 409 colocalization between the dequenching R18 of exosomes and LBPA signals indicated 410 the participation of LBPA in the membrane fusion of exosomes in LEs/MVBs (Fig. 6B) . To 411 verify the dependence of exosome fusion on LBPA, HepG2 cells were pre-incubated with 412 an anti-LBPA blocking antibody(27, 43), and the dequenching signals of R18-labeled 413 exosomes were tracked via time-lapse microscopy. Pretreatment with an anti-LBPA 414 blocking antibody produced significant inhibition of membrane fusion, as suggested by 415 the decayed R18 dequenching of exosomes (Fig. 6C) . The fluorescent intensity profile of 416 tracked fluorescent puncta further manifested the dependence of exosome fusion on 417 LBPA (Fig. 6D ). To inquire into the contribution of LBPA to the potential intracellular 418 release of exosomal cargo before lysosomal degradation, we incubated LBPA-blocked 419
HepG2 cells with GFP-carrying exosomes and judged the delivery efficiency of exosomal 420 cargo to lysosomes based on the colocalization efficiency between GFP and lysosomes. 421
The incidence of colocalization increased significantly in cells pretreated with the 422 anti-LBPA blocking antibody, as indicated by the 2-fold increase in the colocalization 423 coefficient (0.5487) in comparison to control cells (Fig. 6E ). This finding suggested that 424 In this report, we demonstrate that macrophage-derived exosomes utilize virus entry 434 machinery and pathway to proffer IFN-α-induced HBV resistance to hepatocytes. We 435 have presented evidence that macrophage exosomes engage TIM-1, a PtdSer receptor, 436
to enter hepatocytes and undergo rapid CME or sustained macropinocytosis. Our data 437 also suggest that LEs/MVBs are the primary location for LBPA-mediated exosome fusion 438 and accompanying exosomal cargo uncoating for potential intracellular release. The 439 endocytic pathway and membrane fusion in endosomes provide an ideal strategy for 440 exosomes from IFN-α-induced macrophages to deliver antiviral activity and control HBV 441 replication in hepatocytes (Fig. 7) . 442
Exosomes have been shown to interact with membrane receptors on target cells to Exosome entry was inhibited by CPZ or CHC knockdown. The rapid accumulation of 477 exosomes and transferrin in the same transport intermediates affirmed that CME plays a 478 role in early exosome uptake by hepatocytes. However, CAV1 knockdown had no effect 479 on exosome internalization. Considering the low expression of CAV1 in HepG2 cells and 480 primary hepatocytes(52), caveolae-mediated endocytosis may contribute little to 481 exosome uptake by hepatocytes. 482
Furthermore, we found that EIPA, the hallmark inhibitor of macropinocytosis, 483 blocked macrophage exosome entry into hepatocytes. The dependence of exosome 484 entry on PAK1 and PKC was also validated based on the decreased internalization 485 caused by the corresponding kinase inhibitors. In addition, the increasing colocalization 486 of exosomes with dextran during exosome uptake implied that macropinocytosis serves 487 as an efficient alternative route for sustained exosome entry. However, Rac1 and Cdc42, 488
two Rho GTPases that are usually engaged in macropinocytosis, do not appear to be 489 involved in macrophage exosome uptake by hepatocytes. This finding is inconsistent 490 with the interference of exosome entry by EIPA, which inhibits the activation of Rac1 and 491
Cdc42 by altering the sub-membranous pH(42). Therefore, exosome entry into Cdc42-independent macropinocytosis is reportedly invoked during influenza A virus (IAV) 494 entry(53). Related studies also showed that circular ruffling and macropinocytosis 495 independent of Rac1 or Cdc42 could be triggered by the non-receptor tyrosine kinase Using a live cell imaging system and a fusion probe (R18), we found that LEs/MVBs 509 were also the potential site of exosome fusion initiation, followed by cargo uncoating. 510
Notably, the persistence of R18 dequenching signals for several minutes indicated that 511 exosome fusion was trapped in an endosomal sub-compartment, identical to the 512 colocalization of fusion signals with an ILV marker (CD63) ( Fig. 5C and D) (27) . 513
Previous studies have shown that a high concentration of anionic lipids in LEs 514
provides an appropriate environment for endosome penetration(46, 56). It was reported 515 that the presence of anionic lipids in the target membrane promoted membrane fusion 516 efficiency for some enveloped viruses (43, 47, 57) . LBPA is a specific anionic lipid in LEs 517 and is thought to promote ILV budding and back-fusion(55, 58) during MVB biogenesis. 518
Research has suggested that the vesicular stomatitis virus (VSV) loads nucleocapsids 519
into ILVs through membrane fusion and penetrates LEs/MVBs through LBPA-dependent 520 back-fusion between the ILV membrane and the endosome-limiting membrane(43). In 521 addition, LBPA is also required for efficient cytosolic access of delivery vectors, including 522 dfTAT and phosphorothioate-modified antisense oligonucleotides (PS-ASO)(44, 45). 523
Our results showed that the fusion sites of exosomes were colocalized with LBPA. 
